StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultAug 13, 2026, 07:31 AM

FitLife Brands Q2 Revenue Up 65% to $26.5M; Net Income $2.0M

AI Summary

FitLife Brands reported strong Q2 2026 financial results, with total revenue increasing 65% to $26.5 million and net income rising 12% to $2.0 million, largely driven by the acquisition of Irwin Naturals. Adjusted EBITDA also saw a 10% increase to $3.7 million. However, gross margin declined to 37.0% due to the lower margin profile of Irwin Naturals, and Legacy FitLife revenue experienced a 23% decrease. The company also highlighted a significant debt reduction of $8.6 million since the Irwin acquisition.

Key Highlights

  • Total revenue increased 65% to $26.5 million for Q2 2026, driven by the Irwin Naturals acquisition.
  • Net income for Q2 2026 was $2.0 million, up 12% from $1.7 million in Q2 2025.
  • Basic EPS was $0.21 and diluted EPS was $0.20 for Q2 2026.
  • Adjusted EBITDA rose 10% to $3.7 million compared to Q2 2025.
  • Irwin Naturals contributed $14.1 million in revenue, increasing 10% sequentially.
  • Legacy FitLife revenue declined 23% to $12.4 million, primarily due to lower wholesale and online sales.
  • Gross margin decreased to 37.0% from 42.8% in Q2 2025, mainly due to the Irwin acquisition.
  • The company paid off $8.6 million of indebtedness since the Irwin acquisition.